Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.45 -0.03 (-0.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bolt Biotherapeutics (BOLT) Interest & Investment Income (2020 - 2026)

Updated

Bolt Biotherapeutics (BOLT) posted Interest & Investment Income of $178,000 for Q2 2026, down 70.3% from $599,000 a year earlier and down 35.5% from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Interest & Investment Income (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Bolt Biotherapeutics was $1.3 million, down 66.7% year-over-year; for FY2025, it was $2.5 million, down 52.5% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 65.8% (FY2020 to FY2025).
  • In prior years, Bolt Biotherapeutics' Interest & Investment Income was $5.26 million in FY2024 (-24.9%), $7 million in FY2023 (+214.8%), $2.22 million in FY2022 (+691.1%) and $281,000 in FY2021 (+41.2%).
  • The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q4 2021.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last nine quarters, with an average decline of 55.3% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q1 2023, with growth of 624.7%; the weakest was Q1 2026, with a decline of 73.8%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $276,000 (Q1 2026), $367,000 (Q4 2025) and $477,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Bolt Biotherapeutics 6.65 Mn 6.65 Mn - 178,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 178,000.00
Mar 31, 2026 276,000.00
Dec 31, 2025 367,000.00
Sep 30, 2025 477,000.00
Jun 30, 2025 599,000.00
Mar 31, 2025 1.05 Mn
Dec 31, 2024 980,000.00
Sep 30, 2024 1.27 Mn
Jun 30, 2024 1.40 Mn
Mar 31, 2024 1.61 Mn
Dec 31, 2023 1.86 Mn
Sep 30, 2023 1.93 Mn
Jun 30, 2023 1.78 Mn
Mar 31, 2023 1.44 Mn
Dec 31, 2022 1.04 Mn
Sep 30, 2022 587,000.00
Jun 30, 2022 395,000.00
Mar 31, 2022 198,000.00
Dec 31, 2021 -82,000.00
Sep 30, 2021 131,000.00
API Access

Bolt Biotherapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BOLT&period=max&api_key=YOUR_API_KEY